BICX Insider Trading Activity and SEC Form 4 Filings
BICX insider trading summary
No open-market insider purchases or sales of BioCorRx Inc. (BICX) have been reported on SEC Form 4 in the past 12 months.
Latest BICX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 16, 2024 | Louis C. Lucido | Interim President | Buy | $88 (126 @ $0.70) |
| Jan 12, 2024 | Louis C. Lucido | Interim President | Buy | $2K (3,000 @ $0.70) |
| Apr 3, 2023 | Louis C. Lucido | Insider | Buy | $300K (171,296 @ $1.75) |
| Mar 29, 2023 | Joseph J Galligan | Insider | Buy | $300K (171,296 @ $1.75) |
| Jan 30, 2023 | Louis C. Lucido | Insider | Buy | $137 (100 @ $1.37) |
| Jan 30, 2023 | Louis C. Lucido | Insider | Buy | $417 (300 @ $1.39) |
| Jan 26, 2023 | Louis C. Lucido | Insider | Buy | $647 (500 @ $1.29) |
| Jan 24, 2023 | Louis C. Lucido | Insider | Buy | $240 (200 @ $1.20) |
| Jan 13, 2023 | Louis C. Lucido | Insider | Buy | $2K (2,000 @ $1.15) |
| Jan 13, 2023 | Louis C. Lucido | Insider | Buy | $2K (2,000 @ $1.10) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.